From EGFR Signaling to S-Phase Evidence
2026-08-22
A thought-leadership guide to connecting EGFR pathway biology with direct S-phase DNA synthesis measurement. It explains how EdU Imaging Kits (Cy5) can strengthen mechanism-of-action studies, pharmacodynamic decisions, genotoxicity assessment, and translational assay strategy.
FBXO22 Degraders and 2-PCA Recruitment Ligands
2026-08-21
This preprint expands targeted protein degradation by developing chemical tools for the cancer-associated E3 ligase FBXO22. It reports a selective FBXO22 degrader, defines a chain-length requirement for diamine-mediated self-degradation, and introduces 2-pyridinecarboxaldehyde as a reversible electrophilic recruitment ligand capable of directing degradation of BRD4 and CDK12.
Cytochalasin D for Actin Uptake Assays
2026-08-21
Cytochalasin D provides a focused way to test whether actin-dependent internalization contributes to nanoparticle uptake in human corneal epithelial cells. This workflow combines pathway perturbation with viability, morphology, particle-quality, and surface-binding controls so reduced fluorescence is not mistaken for reduced entry.
Superoxide Dismutase Activity Assay Kit Guide
2026-08-20
The Superoxide Dismutase Activity Assay Kit provides a colorimetric way to quantify SOD activity in biological fluids by measuring inhibition of WST-1 reduction at 450 nm. It is intended for controlled research workflows, including oxidative stress studies, and should not be used for diagnosis, patient testing, or therapeutic decisions.
(R)-MG132 in Causal Cancer Metabolism Assays
2026-08-20
(R)-MG132 is an inactive MG-132 enantiomer that helps separate proteasome-dependent effects from nonspecific cellular responses. This guide develops an assay strategy for applying the stereoisomeric control to studies of HNRNPU lactylation, PHGDH, and cervical cancer metabolism.
Chloroquine BA1002: Mechanisms and Research Use
2026-08-19
Chloroquine is a 4-aminoquinoline research compound that raises lysosomal pH, inhibits late-stage autophagic flux, and modulates inflammatory and survival pathways. BA1002 is suited to malaria, rheumatoid arthritis, autophagy, Toll-like receptor, antiviral, and cancer research, but in-vitro activity and research concentrations do not establish clinical efficacy or dosing.
Pharmacological Chaperones Rescue GABAA Epilepsy Variants
2026-08-19
This 2024 study shows that several epilepsy-associated GABAA receptor α1 variants are loss-of-function proteins whose defects arise largely from impaired folding, assembly, and surface trafficking. The positive allosteric modulators Hispidulin and TP003 acted as client-specific pharmacological chaperones, improving receptor proteostasis and function without activating the unfolded protein response in the tested cellular models.
Fosinopril sodium Workflows for ACE Inhibition
2026-08-18
Build reproducible ACE inhibition, vascular-function, and renal hemodynamics assays with Fosinopril sodium. This guide combines mechanism-aware compound handling with endpoint strategies inspired by a large cardiovascular outcomes trial, while clearly separating clinical evidence from bench recommendations.
URB597: A Causal Lens on Endocannabinoid Pain
2026-08-17
URB597 and KDS-4103 provide a selective way to interrogate FAAH-dependent anandamide signaling rather than simply describe pain behavior. This article translates recent cannabidiol findings into assay-selection logic for neuroplasticity, neuroinflammation, and mechanistic pain research.
Electrical Stimulation Boosts Nanoparticle Uptake
2026-08-16
The reference study shows that alternating-current electrical stimulation can increase magnetic nanoparticle endocytosis in cancer cells without requiring particle surface functionalization. By linking enhanced macropinocytosis to reduced F-actin content and elevated intracellular Ca2+, the work offers a potentially transferable strategy for improving magnetic hyperthermia and MRI performance.
Recombinant Human IL-15: Applied Assays
2026-08-15
Build reproducible T-cell and NK-cell workflows with a tag-free, highly active cytokine designed for controlled immune stimulation. This guide connects quantitative IL-15 assays with cautious, exploratory neuroimmune studies inspired by new work on early-life adversity and oxytocin circuitry.
Phosphatase Inhibitor Cocktail 2: Workflow Guide
2026-08-15
Phosphatase Inhibitor Cocktail 2 supports rapid, broad-spectrum preservation of phosphorylation in lysates destined for Western blotting, co-immunoprecipitation, pull-down, and kinase workflows. This guide combines practical 1X preparation with low-temperature handling principles inspired by recent chemical-proteomics research to improve assay consistency without overextending the evidence.
rMeVHu191 Antitumor Effects in Breast Cancer
2026-08-14
Zheng et al. show that recombinant measles virus Hu191 produces multifaceted antitumor effects in breast cancer models, combining apoptosis induction, proliferation suppression, senescence, oxidative-stress changes, and altered lipid homeostasis. The study connects molecular, cellular, transcriptomic, and xenograft evidence, while also identifying questions that require further causal and translational validation.
MAPK10–KRT16 Axis Suppresses NSCLC Metastasis
2026-08-14
The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that limits non-small cell lung cancer metastasis by promoting KRT16 ubiquitination and proteasomal degradation. Its combination of molecular, cellular, animal, and clinical analyses provides a mechanistic framework for interpreting MAPK10 as a metastasis-suppressive biomarker rather than simply another signaling correlate.
Scutellarin, Cathepsin D, and I/R Endothelial Rescue
2026-08-13
This 2025 Frontiers in Pharmacology study identifies cathepsin D–dependent restoration of autophagy-lysosomal function as a mechanism by which scutellarin protects endothelium during cardiac ischemia/reperfusion. Using rat and endothelial-cell models, the authors connect CTSD activity with improved vascular recovery, reduced oxidative and inflammatory injury, and better cardiac outcomes.
464 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page